Abdi İbrahim is a leading player in Turkey's rapidly developing pharmaceutical sector.
Created as a joint venture between Turkish industry leader Abdi İbrahim (60%) and Kazakhstan's Lancaster Group (40%).
Abdi Ibrahim, together with Lancaster Group, created a new company called Abdi Ibrahim Global Pharm to build a modern pharmaceutical plant in Kazakhstan in accordance with the requirements of the GMP standard.
